1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Sylvester RJ, van der Meijden AP,
Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW and
Kurth K: Predicting recurrence and progression in individual
patients with stage Ta T1 bladder cancer using EORTC risk tables: A
combined analysis of 2596 patients from seven EORTC trials. Eur
Urol. 49:466–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kurth KH, Denis L, Bouffioux C, Sylvester
R, Debruyne FM, Pavone-Macaluso M and Oosterlinck W: Factors
affecting recurrence and progression in superficial bladder
tumours. Eur J Cancer. 31A:1–1846. 1995.
|
4
|
Fernandez-Gomez J, Madero R, Solsona E,
Unda M, Martinez-Piñeiro L, Gonzalez M, Portillo J, Ojea A, Pertusa
C, Rodriguez-Molina J, et al: Predicting nonmuscle invasive bladder
cancer recurrence and progression in patients treated with bacillus
Calmette-Guerin: The CUETO scoring model. J Urol. 182:2195–2203.
2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhu H, Li X, Song Y, Zhang P, Xiao Y and
Xing Y: Long non-coding RNA ANRIL is up-regulated in bladder cancer
and regulates bladder cancer cell proliferation and apoptosis
through the intrinsic pathway. Biochem Biophys Res Commun.
467:223–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Dancik GM, Owens CR, Iczkowski KA and
Theodorescu D: A cell of origin gene signature indicates human
bladder cancer has distinct cellular progenitors. Stem Cells.
32:974–982. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Peter S, Borkowska E, Drayton RM, Rakhit
CP, Noon A, Chen W and Catto JW: Identification of differentially
expressed long noncoding RNAs in bladder cancer. Clin Cancer Res.
20:5311–5321. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang Q, Su M, Lu G and Wang J: The
complexity of bladder cancer: Long noncoding RNAs are on the stage.
Mol Cancer. 12:1012013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sun X, Du P, Yuan W, Du Z, Yu M, Yu X and
Hu T: Long non-coding RNA HOTAIR regulates cyclin J via inhibition
of microRNA-205 expression in bladder cancer. Cell Death Dis.
6:e19072015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhuang C, Li J, Liu Y, Chen M, Yuan J, Fu
X, Zhan Y, Liu L, Lin J, Zhou Q, et al: Tetracycline-inducible
shRNA targeting long non-coding RNA PVT1 inhibits cell growth and
induces apoptosis in bladder cancer cells. Oncotarget.
6:41194–41203. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Martin L and Chang HY: Uncovering the role
of genomic ‘dark matter’ in human disease. J Clin Invest.
122:1589–1595. 2012. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Wang Y, He L, Du Y, Zhu P, Huang G, Luo J,
Yan X, Ye B, Li C, Xia P, et al: The long noncoding RNA lncTCF7
promotes self-renewal of human liver cancer stem cells through
activation of Wnt signaling. Cell Stem Cell. 16:413–425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Han X, Yang F, Cao H and Liang Z: Malat1
regulates serum response factor through miR-133 as a competing
endogenous RNA in myogenesis. FASEB J. 29:3054–3064. 2015.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Li P, Ruan X, Yang L, Kiesewetter K, Zhao
Y, Luo H, Chen Y, Gucek M, Zhu J and Cao H: A liver-enriched long
non-coding RNA, lncLSTR, regulates systemic lipid metabolism in
mice. Cell Metab. 21:455–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Han P, Li W, Lin CH, Yang J, Shang C,
Nuernberg ST, Jin KK, Xu W, Lin CY, Lin CJ, et al: A long noncoding
RNA protects the heart from pathological hypertrophy. Nature.
514:102–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Panzitt K, Tschernatsch MM, Guelly C,
Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder
R, Trauner M and Zatloukal K: Characterization of HULC, a novel
gene with striking up-regulation in hepatocellular carcinoma, as
noncoding RNA. Gastroenterology. 132:330–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wu W, Zhang S, Li X, Xue M, Cao S and Chen
W: Ets-2 regulates cell apoptosis via the Akt pathway, through the
regulation of urothelial cancer associated 1, a long non-coding
RNA, in bladder cancer cells. PLoS One. 8:e739202013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhuang J, Lu Q, Shen B, Huang X, Shen L,
Zheng X, Huang R, Yan J and Guo H: TGFβ1 secreted by
cancer-associated fibroblasts induces epithelial-mesenchymal
transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci Rep.
5:119242015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yang X, Song JH, Cheng Y, Wu W, Bhagat T,
Yu Y, Abraham JM, Ibrahim S, Ravich W, Roland BC, et al: Long
non-coding RNA HNF1A-AS1 regulates proliferation and migration in
oesophageal adenocarcinoma cells. Gut. 63:881–890. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wu Y, Liu H, Shi X, Yao Y, Yang W and Song
Y: The long non-coding RNA HNF1A-AS1 regulates proliferation and
metastasis in lung adenocarcinoma. Oncotarget. 6:9160–9172.
2015.PubMed/NCBI
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Millán-Rodríguez F, Chéchile-Toniolo G,
Salvador-Bayarri J, Palou J, Algaba F and Vicente-Rodríguez J:
Primary superficial bladder cancer risk groups according to
progression, mortality and recurrence. J Urol. 164:680–684. 2000.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Rübben H, Lutzeyer W, Fischer N, Deutz F,
Lagrange W and Giani G: Natural history and treatment of low and
high risk superficial bladder tumors. J Urol. 139:283–285. 1988.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Dang Y, Lan F, Ouyang X, Wang K, Lin Y, Yu
Y, Wang L, Wang Y and Huang Q: Expression and clinical significance
of long non-coding RNA HNF1A-AS1 in human gastric cancer. World J
Surg Oncol. 13:3022015. View Article : Google Scholar : PubMed/NCBI
|